Biotechnology company focused on cellular rejuvenation programming
Altos is dedicated to unraveling the deep biology of cellular rejuvenation programming. Our mission is to restore cell health and resilience to reverse disease, injury, and disabilities that occur throughout life.
The Altos Institutes of Science will pursue deep scientific questions and integrate their findings into one collaborative research effort. The Altos Institute of Medicine will capture knowledge generated about cell health and programming and develop transformative medicines.
Visit website: https://altoslabs.com/
People at Altos Labs
Founding Principal Investigator at Altos labs, Authored True Age book
Principal Investigator at AltosLabs and researcher at Max Planck Institute for Biology of Ageing
President Research And Development at GSK, former president of research and development at Calico and incoming CEO at Altos Labs
Chief Scientist and Founder at Altos Labs
Altos Labs News
The Observer interviews Morgan Levine about ageing and her move to Altos Labs
The Guardian - 07-May-2022
When it comes to lifespan, you cannot blame 100% on genetics, just 10-30%Read more...
Long-term partial reprogramming reversed ageing process in mice
The Guardian - 07-Mar-2022
Yamanaka factors restored youthfullness in aged cells, raised hope for new anti-ageing therapiesRead more...
Altos Labs comes out of stealth with $3 billion of capital
Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022
Huge backing that cellular reprogramming can have a significant impact on health and ageingRead more...